Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phreesia, Inc. (PHR) Q1 2027 Earnings Call Transcript
Phreesia NYSE: PHR reported higher first-quarter revenue and profitability for fiscal 2027, with executives pointing to growth in payment solutions, expanding opportunities from its AccessOne acquisition and continued investment in patient intake, provider engagement and artificial intelligence.
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Phreesia (PHR) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.07 per share a year ago.
Beyond analysts' top-and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2026.
For years, Phreesia, Inc. NYSE: PHR has seen its stock price struggle. Those challenges have come at no fault of its own other, but rather as a consequence of its growth, which has been funded by share counts and debt.
Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
Beyond analysts' top-and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2026.
Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Phreesia is at a pivotal growth stage, achieving GAAP profitability and strong adjusted EBITDA momentum. PHR's AccessOne acquisition enhances its platform with payment and financing capabilities, supporting margin expansion and revenue quality. Despite conservative FY2026 guidance and technical headwinds, PHR trades at a significant discount to peers, with improving fundamentals.
Phreesia (PHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.